CYTOMEGALOVIRUS INFECTIONS
Clinical trials for CYTOMEGALOVIRUS INFECTIONS explained in plain language.
Never miss a new study
Get alerted when new CYTOMEGALOVIRUS INFECTIONS trials appear
Sign up with your email to follow new studies for CYTOMEGALOVIRUS INFECTIONS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Experimental immune cell therapy targets Post-Transplant virus
Disease control Recruiting nowThis study tests whether specially selected immune cells from a donor can safely treat cytomegalovirus (CMV) infection in people who have had a stem cell transplant. About 20 participants will receive an infusion of donor T-cells that are trained to attack CMV. The main goal is t…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: EARLY_PHASE1 • Sponsor: Mari Dallas • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New approach could reduce harsh drug side effects for transplant patients fighting CMV
Disease control Recruiting nowThis study is testing whether a drug called letermovir can prevent cytomegalovirus (CMV) infections from coming back in high-risk kidney or kidney/pancreas transplant patients. Researchers want to see if switching to letermovir earlier than usual can reduce the time patients need…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE3 • Sponsor: University of Wisconsin, Madison • Aim: Disease control
Last updated Apr 15, 2026 16:16 UTC
-
New software could speed up CMV diagnosis in pregnant women
Diagnosis Recruiting nowThis study tests a software tool called MyCMV that helps doctors interpret blood test results for cytomegalovirus (CMV) infection during pregnancy. CMV is a common virus that can cause hearing loss and developmental problems in babies if the mother gets infected while pregnant. T…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated May 18, 2026 12:01 UTC
-
Immune-Guided drug timing could cut CMV prevention after transplant
Prevention Recruiting nowThis study tests a personalized approach to prevent cytomegalovirus (CMV) infection in adults who have received a stem cell transplant. Instead of giving the anti-CMV drug letermovir for a fixed 100 days, researchers will use a blood test to check when each patient's immune syste…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: PHASE4 • Sponsor: WeiShi • Aim: Prevention
Last updated May 26, 2026 04:54 UTC
-
New hope for transplant patients: extended drug course may stop dangerous virus
Prevention Recruiting nowThis study tests whether taking letermovir for a longer time (up to 28 weeks) can prevent cytomegalovirus (CMV) infection in 330 high-risk Chinese adults who have received a stem cell transplant. CMV is a common and serious complication in these patients because their immune syst…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Phase: NA • Sponsor: The First Affiliated Hospital of Soochow University • Aim: Prevention
Last updated May 11, 2026 20:39 UTC
-
Lung transplant study tracks hidden virus breakthroughs
Knowledge-focused Recruiting nowThis study follows 40 lung transplant patients who are at high risk for CMV infection because the donor had CMV but the recipient did not. Researchers want to see how often the virus shows up in the blood while patients are taking the antiviral drug valganciclovir. They will also…
Matched conditions: CYTOMEGALOVIRUS INFECTIONS
Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated May 26, 2026 04:52 UTC